Correlation Between DexCom and Novacyt SA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DexCom and Novacyt SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DexCom and Novacyt SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DexCom Inc and Novacyt SA, you can compare the effects of market volatilities on DexCom and Novacyt SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DexCom with a short position of Novacyt SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of DexCom and Novacyt SA.

Diversification Opportunities for DexCom and Novacyt SA

-0.87
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between DexCom and Novacyt is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding DexCom Inc and Novacyt SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novacyt SA and DexCom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DexCom Inc are associated (or correlated) with Novacyt SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novacyt SA has no effect on the direction of DexCom i.e., DexCom and Novacyt SA go up and down completely randomly.

Pair Corralation between DexCom and Novacyt SA

Given the investment horizon of 90 days DexCom Inc is expected to generate 0.44 times more return on investment than Novacyt SA. However, DexCom Inc is 2.29 times less risky than Novacyt SA. It trades about 0.08 of its potential returns per unit of risk. Novacyt SA is currently generating about -0.11 per unit of risk. If you would invest  6,970  in DexCom Inc on September 21, 2024 and sell it today you would earn a total of  612.00  from holding DexCom Inc or generate 8.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

DexCom Inc  vs.  Novacyt SA

 Performance 
       Timeline  
DexCom Inc 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in DexCom Inc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, DexCom may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Novacyt SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novacyt SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

DexCom and Novacyt SA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DexCom and Novacyt SA

The main advantage of trading using opposite DexCom and Novacyt SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DexCom position performs unexpectedly, Novacyt SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novacyt SA will offset losses from the drop in Novacyt SA's long position.
The idea behind DexCom Inc and Novacyt SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA